The AAFP recently joined more than a hundred other national and state physician organizations in the medical community's latest attempt to rectify an overreach CMS made back in 2013. By throwing its support behind legislation that is intended to clarify what is and isn't reportable under the Physician Payments Sunshine Act, the Academy seeks to safeguard physicians' unfettered access to high-quality educational resources and independent certified and/or accredited CME.
Anti-industry activists continue to mislead the public about the rules and regulations governing accredited continuing medical education (CME) in order to promote their “pharma-scare” narrative. On the contrary, accredited CME is the trusted mainstay of post-graduate physician learning and provides the primary means by which innovation and discovery are brought to the patient bedside.
FOR IMMEDIATE RELEASE
Contact: Andrew Rosenberg, (202) 247-6301
December 17, 2015 – Today, the CME Coalition responded to an opinion piece written by noted critics of continuing medical education (CME) affiliated with the group, Pharmed Out, in the Journal of Medical Ethics.
According to CME Coalition Senior Advisor Andrew Rosenberg, “It is becoming tiresome to have to respond to this continuous barrage of misinformation and outright untruths from PharmedOut, but we feel compelled to again correct the record.”
In a recent article on the House-passed ‘21st Century Cures Act,’ Policy and Medicine reports that despite an overwhelming display of support in the House, the Senate is operating at a slower pace in advancing legislation that includes an important Sunshine Act reporting exemption for CME. As detailed in the article, a key provision in ‘21st Century Cures’ would exempt certain “transfers of value” related to CME from the Sunshine Act’s reporting requirements.
Prior to a vote in the House last July, Energy and Commerce Committee Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO)—co-authors of the ‘21st Century Cures Act’—had emphasized the need to incorporate stakeholders from FDA, NIH, private industry, academic, patients, and other areas to produce better health outcomes. Encouragingly, the legislation received letters of support from hundreds of organizations, including patient groups, the Association of American Medical Colleges, sixty-seven cancer institutes, and seventy-five research, life sciences, and patient advocacy organizations.
In an article issued in The Journal of the American Medical Association (JAMA), the Accreditation Council for Continuing Medical Education (ACCME) authored "Advancing Continuing Medical Education," by Graham McMahon, MD, MMSc, President and CEO of the ACCME. Dr. McMahon articulates the importance of accredited CME in supporting physicians' continuing professional development and the evolving healthcare environment. He explains the evolution of CME over the past 15 years, as increasingly CME has been designed to create meaningful change in healthcare professionals' skills and performance and to affect patient outcomes.
A new article published in Policy and Medicine highlights bipartisan efforts in Congress to pass a broad regulatory overhaul known as '21st Century Cures,' which includes an important provision that would exempt certain "transfers of value" related to CME from the Sunshine Act's reporting requirements. This bipartisan provision, based on legislation introduced by Reps. Michael Burgess (R-TX) and Peter DeFazio (D-OR), would encourage continued physician participation in CME events without concern for being publicly reported in a database for having received payments from commercial supporters. In response to the advancement of this bill, Andrew Rosenberg of the CME Coalition said that Congress "has demonstrated the commitment to CME as a bipartisan issue."
This post was originally published in MeetingsNet by Rockpointe President and CME Coalition member, Tom Sullivan.
The past month, Congress did something that one may consider amazing. House Speaker John Boehner, R-Ohio, and Minority Leader Nancy Pelosi, D-Calif., sat down and agreed to permanently fix the Medicare Sustainable Growth Rate, or SGR. Then both the House and Senate passed their bill, which was signed by President Obama on a beautiful spring day. The ease of the whole process may seem like an omen to those who have followed doc fix after doc fix on the path to SGR repeal.